Cancer represents a significant cause of death and suffering in both the developed and
developing countries. Key underlying issues in the mortality of cancer are delayed diagnosis …

Sex differences are present across multiple non-reproductive organ cancers, with male
individuals generally experiencing higher incidence of cancer with poorer outcomes …

A wide sex disparity has been demonstrated in cancer incidence, tumor aggressiveness,
prognosis, and treatment response of different types of cancer. The sex specificity of cancer …

The processes of cancer initiation, progression, and response to therapy are affected by the
sex of cancer patients. Immunotherapy responses largely depend on the tumor …

The global burden of cancer is growing and a wide disparity in the incidence, malignancy
and mortality of different types of cancer between each sex has been demonstrated. The sex …

Cancers are heterogeneous multifactorial diseases consisting of a major public health issue
worldwide. Sex disparities are evidenced in cancer incidence, mortality, expression of …

Recent evidence highlights patients' sex relevance in antitumor immune response through a
complex interaction—among hormones, genes, behaviors, and the microbiome—that affects …

Sex differences in cancer incidence and survival are constant and pronounced globally,
across all races and all age groups of cancer types. In 2016, after the National Institutes of …

The cancer research field is finally starting to unravel the mystery behind why males have a
higher incidence and mortality rate than females for nearly all cancer types of the non …

Across the wide range of clinical conditions, there exists a sex imbalance where biological
females are more prone to autoimmune diseases and males to some cancers. These …